Drugmaker Aegerion’s Chapter 11 plan confirmed in New York

Bankrupt US drugmaker Aegerion’s Chapter 11 plan, which envisages it sold to European rival Amryt Pharma, has been confirmed by a New York bankruptcy court.

Get unlimited access to all Global Restructuring Review content